FDA warns companies for promoting alternatives to street drugs Ruby Khatun Khatun18 Dec 2017 10:29 AM ISTThe U.S. Food and Drug Administration (FDA) posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a...
Pfizer gets USFDA approval for second biosimilar of Remicade Ruby Khatun Khatun18 Dec 2017 10:15 AM ISTThe U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
Aclaris's drug to treat common skin growth gets FDA nod Ruby Khatun Khatun18 Dec 2017 10:00 AM ISTAclaris Therapeutics Inc's drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug...
Canadian police probe mysterious deaths of billionaire pharma couple Ruby Khatun Khatun18 Dec 2017 9:45 AM ISTTORONTO: Canadian police are investigating the mysterious deaths of pharmaceuticals billionaire Barry Sherman, founder of Apotex Inc, and his wife...
Novartis generics arm says may sell or end some products Ruby Khatun Khatun18 Dec 2017 9:30 AM ISTZURICH: Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on...
Ranbaxy Labs- no longer Indian pharmaceutical sector's backbone- Report Ruby Khatun Khatun17 Dec 2017 12:30 PM ISTNew Delhi (ANI report): In recent times, standards of corporate governance and responsibility have been questioned, so much so, that the Securities...
15,000 diabetics sign petition to slash glucostrips price Ruby Khatun Khatun17 Dec 2017 11:00 AM ISTMumbai: In a move to curb the price of glucostrips more than 15,000 people have signed an online petition seeking a reduction in the cost of...
Siemens buys Fast Track Diagnostics to boost molecular offering Ruby Khatun Khatun17 Dec 2017 10:45 AM ISTFRANKFURT: Siemens said it has agreed to buy Luxembourg-based Fast Track Diagnostics to boost its molecular-testing offering, one of the areas it is...
Pfizer gets FDA nod for Xeljanz for joint disease treatment Ruby Khatun Khatun17 Dec 2017 10:30 AM ISTU.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint...
Medtronic settles states probe into Infuse marketing for 12 million dollars Ruby Khatun Khatun17 Dec 2017 10:15 AM ISTBOSTON: Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse...
Govt fixes ceiling prices of 849 formulations till Nov Ruby Khatun Khatun17 Dec 2017 10:06 AM ISTNew Delhi: The government has fixed ceiling prices of 849 formulations, including two coronary stents, till November 2017, Parliament was informed...
MedGenome receives accreditation from the College of American Pathologists Ruby Khatun Khatun17 Dec 2017 10:00 AM ISTBengaluru: MedGenome, India’s market leader in genetic diagnostics announced that its NGS (Next Generation Sequencing) technology based clinical...
